Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Placebo can bring emotional relief

17.06.2005


Just as placebos have been shown to bring relief from pain, researchers have now found that they can affect emotion, alleviating the impact of unpleasant experiences. In an article in the June 16, 2005, issue of Neuron, researchers led by Predrag Petrovic of the Karolinska Institutet show that, in relieving anxiety, placebo treatment affects the same basic modulatory circuitry in the brain as it does for relieving pain.



In their experiments, the researchers tested the effect of placebo treatment on volunteer subjects’ ratings of unpleasant pictures, such as images of mutilated bodies. Other researchers had shown that people’s expectation of pain relief plays a major role in the effectiveness of placebos. So, in their experiments, the researchers first induced such an expectation in the subjects by administering an antianxiety drug to reduce the subjects’ unpleasant perception of the pictures. They then administered an antidote to the drug, telling the subjects that it would restore the unpleasant perception.

In tests the following day, the subjects were told they would receive the same drugs. But instead, they received a saline solution as a placebo when they saw the pictures. The subjects’ brains were also scanned during these experiments using functional magnetic resonance imaging (fMRI). This scanning technique uses harmless magnetic fields and radio waves to measure blood flow in brain regions, which reflects brain activity.


The researchers found that the placebo reduced the subjects’ ratings of the unpleasant pictures by about 29%. Importantly, the fMRI scans showed that the placebo reduced activity in the brain’s emotional centers, and this reduction correlated with a subject’s amount of reduction in the rated unpleasantness of the pictures. That is, the subjects who reported the largest placebo response also showed the largest decrease in activity in the emotional centers.

Also importantly, the placebo increased brain activity in the same “modulatory network” whose activity is increased when placebos have been used to relieve pain.

The researchers found that, as in placebo treatment for pain, expectation played a major role in effectiveness. Those subjects who expected the largest effect—as measured by the effect they reported from the real antianxiety drug the previous day—showed the largest changes in activity in the emotional and modulatory areas.

“The present data demonstrate that emotional experience may be modulated through a placebo treatment in a similar manner as has been previously reported for pain perception,” concluded Petrovic and his colleagues. They wrote that the study “demonstrated that very similar mechanisms are involved in the placebo response of emotional stimuli and in placebo analgesia, thereby generalizing the concept of placebo and its associated underlying neural processes.” They also concluded that the placebo effect can be thought of “as a general process of modulation induced by the subjects’ expectations, possibly using specific modulating systems.”

The researchers include Predrag Petrovic, Thomas Dietrich, Peter Fransson, Jesper Andersson, Katrina Carlsson, and Martin Ingvar of the Cognitive Neurophysiology Research Group R2-01 of the Department of Clinical Neuroscience at Karolinska Institutet in Stockholm, Sweden. This study was supported by grants from the Swedish Medical Research Council, Förenade Liv, the Karolinska Institute, the Swedish Medical Association, the Knut and Alice Wallenberg foundation, and the Petrus and Augusta Hedlunds foundation.

Dr Predrag Petrovic | alfa
Further information:
http://info.ki.se/article_en.html?ID=3942

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>